Class Action Lawsuit Reminder for Rocket Pharmaceuticals, Inc. (RCKT) by Levi & Korsinsky

Investors who purchased RCKT stock between May 06, 2021, and July 01, 2023, may be eligible to participate in a class-action lawsuit. Levi & Korsinsky has reminded investors that the deadline to join the lawsuit is August 11, 2025.

The class-action lawsuit alleges that RCKT made misleading statements about the efficacy and safety of its products, specifically focusing on the company’s drug pipeline and clinical trials. Investors who suffered financial losses due to these alleged misrepresentations are encouraged to join the lawsuit before the upcoming deadline.

Investors who purchased RCKT stock during the specified timeframe and wish to be part of the lawsuit must act promptly. Levi & Korsinsky, a prominent law firm specializing in securities litigation, is committed to holding companies accountable for any misleading or deceptive practices that harm investors.

The deadline to join the class-action lawsuit is rapidly approaching, and investors who believe they were affected by RCKT’s alleged misrepresentations should not hesitate to seek legal recourse. Levi & Korsinsky is dedicated to fighting for the rights of investors who have suffered losses as a result of fraudulent practices in the market.

Investors who have any questions or concerns about the class-action lawsuit against RCKT are urged to contact Levi & Korsinsky for more information. The firm’s experienced team of attorneys is available to provide guidance and support to investors who wish to participate in the lawsuit before the August 11, 2025 deadline.

The allegations against RCKT suggest that the company may have provided misleading information to investors regarding the performance of its products and the outcomes of its clinical trials. As a result, investors who suffered financial losses during the specified period may have grounds to seek compensation through the class-action lawsuit.

Levi & Korsinsky is dedicated to upholding the rights of investors and ensuring that companies are held accountable for any deceptive practices that may have harmed shareholders. Investors who believe they were affected by RCKT’s alleged misrepresentations are encouraged to join the lawsuit before the deadline to seek potential compensation for their losses.

The deadline to join the class-action lawsuit against RCKT is fast approaching, and investors who wish to participate should not delay in taking action. Levi & Korsinsky is prepared to assist investors in pursuing their claims and seeking justice for any financial harm they may have suffered as a result of the alleged misconduct by RCKT.